⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10731186 | 0.82 | — | — | |
| SCHEMBL19600557 | 0.79 | — | — | |
| SCHEMBL1126335 | 0.77 | — | — | |
| SCHEMBL5266758 | 0.75 | — | — | |
| SCHEMBL1275932 | 0.72 | — | — | |
| SCHEMBL698327 | 0.69 | — | — | |
| SCHEMBL4699 | 0.67 | — | — | |
| SCHEMBL2885270 | 0.67 | — | — | |
| SCHEMBL1332124 | 0.67 | — | — | |
| SCHEMBL2082322 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12279520-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2025-04-15 | — | — | US | disclosed |
| US-20240217992-A1 | RETINOIC ACID RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE | Jiangxi Kerui Pharmaceutical Co., Ltd. (CN) | 2024-07-04 | — | — | US | disclosed |
| US-20230165134-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230165134-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-05-25 | — | — | US | disclosed |
| US-20210376261-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-12-02 | — | — | US | disclosed |
| US-9518069-B2 | Catalytic method for obtaining substituted (triorganosilyl)alkynes and their derivatives | ADAM MICKIEWICZ UNIVERSITY (PL) | 2016-12-13 | — | — | US | disclosed |
| EP-2658861-B1 | NEW (TRIORGANOSILYL)ALKYNES AND THEIR DERIVATIVES AND A NEW CATALYTIC METHOD FOR OBTAINING NEW AND CONVENTIONAL SUBSTITUTED (TRIORGANOSILYL)ALKYNES AND THEIR DERIVATIVES | UNIV ADAM MICKIEWICZ (PL) | 2016-10-12 | — | — | EP | disclosed |
| US-20150361111-A1 | Catalytic method for obtaining substituted (triorganosilyl)alkynes and their derivatives | UNIV ADAM MICKIEWICZ (PL) | 2015-12-17 | — | — | US | disclosed |
| US-9108994-B2 | (Triorganosilyl)alkynes and their derivatives and a new catalytic method for obtaining new and conventional substituted (triorganosilyl)alkynes and their derivatives | ADAM MICKIEWICZ UNIVERSITY (PL) | 2015-08-18 | — | — | US | disclosed |
| US-8765719-B2 | Therapeutic drug for adult T-cell leukemia | KAGOSHIMA UNIVERSITY (JP) | 2014-07-01 | — | — | US | disclosed |
| EP-2345409-A1 | THERAPEUTIC AGENT FOR ADULT T-CELL LEUKEMIA | Kagoshima University (JP) | 2011-07-20 | — | — | EP | disclosed |
| US-20110172185-A1 | THERAPEUTIC DRUG FOR ADULT T-CELL LEUKEMIA | KAGOSHIMA UNIVERSITY (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20110172185-A1 | THERAPEUTIC DRUG FOR ADULT T-CELL LEUKEMIA | KAGOSHIMA UNIVERSITY (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20070111967-A1 | Organosilicon compounds and their use | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-05-17 | — | — | US | disclosed |
| EP-1572610-B1 | METHOD FOR THE PRODUCTION OF 1.6-HEXANEDIOL | BASF AG (DE) | 2006-08-02 | — | — | EP | disclosed |
| EP-1562611-B1 | HETEROCYCLIC SILICON COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH GNRH (GONADOTROPIN-RELEASING HORMONE) | PARADIGM THERAPEUTICS LTD (GB) | 2006-08-02 | — | — | EP | disclosed |
| US-20060052344-A1 | Heterocyclic silicon compounds and their use in the treatment of diseases or conditions associated with gnrh (gonadotropin-releasing hormone) | PARADIGM THERAPEUTICS LTD. (GB) | 2006-03-09 | — | — | US | disclosed |
| EP-1562611-A1 | HETEROCYCLIC SILICON COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH GNRH (GONADOTROPIN-RELEASING HORMONE) | Amedis Pharmaceuticals Limited (GB) | 2005-08-17 | — | — | EP | disclosed |
| WO-2004048390-A1 | SILICON COMPOUNDS | AMEDIS PHARMACEUTICALS LTD. (GB) | 2004-06-10 | — | — | WO | disclosed |
| WO-2004045625-A1 | HETEROCYCLIC SILICON COMPOUNDS AND THEIR USE IN THE TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH GNRH (GONADOTROPIN-RELEASING HORMONE) | PARADIGM THERAPEUTICS LTD. (GB) | 2004-06-03 | — | — | WO | disclosed |